Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Arbuthnot

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Scientific Reports|February 4, 2017
Longitudinal in vivo bioimaging of hepatocyte transcription factor activity following cholestatic liver injury in miceJuliette M K M Delhove, Suzanne M K Buckley, Dany P Perocheau, et al.
Hepatology (Baltimore, Md.)|February 24, 2006
Enhanced cell survival of Hep3B cells by the hepatitis B x antigen effector, URG11, is associated with upregulation of beta-cateninZhaorui Lian, Jie Liu, Li Li, et al.
Molecular Carcinogenesis|April 27, 2004
Human S15a expression is upregulated by hepatitis B virus X proteinZhaorui Lian, Jie Liu, Li Li, et al.
Molecular Pharmaceutics|January 23, 2009
Controlling HBV replication in vivo by intravenous administration of triggered PEGylated siRNA-nanoparticlesSergio Carmona, Michael R Jorgensen, Soumia Kolli, et al.
Neoplasia (New York, N.Y.)|July 19, 2003
Upregulated expression of a unique gene by hepatitis B x antigen promotes hepatocellular growth and tumorigenesisZhaorui Lian, Jie Liu, Li Li, et al.
The Lancet. Infectious Diseases|June 8, 2023
Opportunities and challenges of leveraging COVID-19 vaccine innovation and technologies for developing sustainable vaccine manufacturing capabilities in AfricaBavesh D Kana, Patrick Arbuthnot, Benjamin K Botwe, et al.
Artificial DNA, PNA & XNA|June 21, 2011
Inhibition of hepatitis B virus replication in vivo using lipoplexes containing altritol-modified antiviral siRNAsJustin Hean, Carol Crowther, Abdullah Ely, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 9, 2009
DODAG; a versatile new cationic lipid that mediates efficient delivery of pDNA and siRNAMathieu Mével, Nazila Kamaly, Sergio Carmona, et al.
Scientific Reports|July 4, 2015
In vivo bioimaging with tissue-specific transcription factor activated luciferase reportersSuzanne M K Buckley, Juliette M K M Delhove, Dany P Perocheau, et al.
BMJ Global Health|August 27, 2025
Advancing the course of HIV genomics research in AfricaFrancis E Agamah, Patrick Arbuthnot, Paulina Tindana, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Scientific Reports|February 4, 2017
Longitudinal in vivo bioimaging of hepatocyte transcription factor activity following cholestatic liver injury in miceJuliette M K M Delhove, Suzanne M K Buckley, Dany P Perocheau, et al.
Hepatology (Baltimore, Md.)|February 24, 2006
Enhanced cell survival of Hep3B cells by the hepatitis B x antigen effector, URG11, is associated with upregulation of beta-cateninZhaorui Lian, Jie Liu, Li Li, et al.
Molecular Carcinogenesis|April 27, 2004
Human S15a expression is upregulated by hepatitis B virus X proteinZhaorui Lian, Jie Liu, Li Li, et al.
Molecular Pharmaceutics|January 23, 2009
Controlling HBV replication in vivo by intravenous administration of triggered PEGylated siRNA-nanoparticlesSergio Carmona, Michael R Jorgensen, Soumia Kolli, et al.
Neoplasia (New York, N.Y.)|July 19, 2003
Upregulated expression of a unique gene by hepatitis B x antigen promotes hepatocellular growth and tumorigenesisZhaorui Lian, Jie Liu, Li Li, et al.
The Lancet. Infectious Diseases|June 8, 2023
Opportunities and challenges of leveraging COVID-19 vaccine innovation and technologies for developing sustainable vaccine manufacturing capabilities in AfricaBavesh D Kana, Patrick Arbuthnot, Benjamin K Botwe, et al.
Artificial DNA, PNA & XNA|June 21, 2011
Inhibition of hepatitis B virus replication in vivo using lipoplexes containing altritol-modified antiviral siRNAsJustin Hean, Carol Crowther, Abdullah Ely, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 9, 2009
DODAG; a versatile new cationic lipid that mediates efficient delivery of pDNA and siRNAMathieu Mével, Nazila Kamaly, Sergio Carmona, et al.
Scientific Reports|July 4, 2015
In vivo bioimaging with tissue-specific transcription factor activated luciferase reportersSuzanne M K Buckley, Juliette M K M Delhove, Dany P Perocheau, et al.
BMJ Global Health|August 27, 2025
Advancing the course of HIV genomics research in AfricaFrancis E Agamah, Patrick Arbuthnot, Paulina Tindana, et al.
Pageof 11